wledge-based contract research, medical communications and consulting
services to the worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite time-to-market
and peak-market penetration, PAREXEL has developed significant expertise
across the development and commercialization continuum, from drug
development and regulatory consulting to clinical pharmacology, clinical
trials management, medical education and reimbursement. Perceptive
Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology
solutions, including medical imaging, to facilitate the clinical
development process. Headquartered near Boston, Massachusetts, PAREXEL
operates in 63 locations throughout 52 countries around the world, and has
more than 7,600 employees. For more information about PAREXEL International
visit
http://www.PAREXEL.com.
This release contains "forward-looking" statements regarding future
results and events. For this purpose, any statements contained herein that
are not statements of historical fact may be deemed forward-looking
statements. Without limiting the foregoing, the words "believes,"
"anticipates," "plans," "expects," "intends," "appears," "estimates,"
"projects," "targets," and similar expressions are also intended to
identify forward-looking statements. The forward-looking statements in this
release involve a number of risks and uncertainties. The Company's actual
future results may differ significantly from the results discussed in the
forward-looking statements contained in this release. Important factors
that might cause such a difference include, but are not limited to, risks
associated with: actual operating performance; actual expense savings and
other operating improvements resulting from recent restructurings; the
loss, modification, or delay of contracts which would, among other things,
adversely impact the Company's recognition of rev
'/>"/>
SOURCE PAREXEL International Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference2.
Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe3.
PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.4.
PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors5.
PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call6.
PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results7.
PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities8.
PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call9.
PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors10.
PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results11.
PAREXEL International Announces 2-For-1 Stock Split